The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment.

Background: The number of percutaneous coronary interventions (PCI) with bioresorbable vascular scaffolds (BVS) is in-creasing because these procedures offer additional benefits compared to PCI with classical drug eluting stents (DES) made of permanent metallic prostheses.

Aim: To present the current experience of using BVS in a real life scenario in patients with stable coronary artery disease (CAD), with a special focus on the assessment of safety and effectiveness of the hybrid strategy (single stage BVS and DES implantation).

Methods: We performed a one-arm prospective registry, which enrolled patients with stable CAD in five interventional cardiology centres in Poland.